A novel defined TLR3 agonist as an effective vaccine adjuvant
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1075291
Abstract: Synthetic double-stranded RNA analogs recognized by Toll-like receptor 3 (TLR3) are an attractive adjuvant candidate for vaccines, especially against intracellular pathogens or tumors, because of their ability to enhance T cell and antibody responses. Although… read more here.
Keywords: agonist effective; defined tlr3; tlr3 agonist; novel defined ... See more keywords